Cargando…
Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy
The molecular events leading to gastroenteropancreatic neuroendocrine tumor (GEP-NET) formation are largely unknown. Over the past decades, systemic chemotherapies have been replaced by therapies directed at particular molecular targets such as the somatostatin receptors, mTOR complexes or proangiog...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722794/ https://www.ncbi.nlm.nih.gov/pubmed/29255447 http://dx.doi.org/10.3389/fendo.2017.00341 |